How pathogens are killed

October 06, 2011 11:32 pm | Updated November 17, 2021 12:55 am IST

Inside our body can be found the bloodiest of battlefields, where millions of organisms are massacred daily, without cease. It is a battle waged by our body's robust immune system against a wide variety of pathogenic bacteria, virus, fungi, and parasites. What makes the defence mechanism powerful is the two-level protection conferred by the immune system. The innate immune system that serves as the first line of defence is not antigen-specific; it readily targets all pathogenic organisms the moment they enter the body. The antigen-specific adaptive immune mechanism acts as the second line of protection to keep us healthy. This year's Nobel Prize in Physiology or Medicine has been awarded to Bruce A. Beutler, Jules A. Hoffmann, and Ralph M. Steinman for revolutionising our understanding of the immune system by discovering the key principles that activate the defence mechanism. Beutler and Hoffmann will share half the prize money for discovering the receptor proteins that recognise micro-organisms and activate the innate immunity. In 1996, Hoffmann found that the Toll gene was responsible for sensing pathogenic micro-organisms and that its activation was required for mounting innate immune response. Two years later, Beutler discovered that components of micro-organisms bind to Toll-like receptors located on many cells. The binding activates the innate immunity, which results in inflammation and destruction of the pathogens.

The other half of the prize money was awarded to Steinmann for discovering, way back in the 1970s, that dendritic cells were responsible for adaptive immunity. As they are antigen-specific, dendritic cells take time to react to an invading organism on first exposure; but immunological memory allows them to react more rapidly to the same antigen on subsequent exposures. This is the attribute researchers exploit while designing preventive vaccines. Adaptive immunity holds great medical promise. The immune system can be directed to attack the tumour. Blocking the excessive production of cytokines when diseases show up can ameliorate autoimmunity. Even preventing autoimmune diseases may become possible when certain cells of the immune system are successfully silenced. Steinmann will go down in history as not just a highly worthy Nobel Prize winner. He was (as a Rockefeller University statement explains) “diagnosed with pancreatic cancer four years ago ... his life was extended using a dendritic-cell based immunotherapy of his own design,” and he died three days before his Nobel was announced.

Top News Today

Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in


Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.